-
Y-mAbs Therapeutics' (YMAB) Buy Rating Reaffirmed at HC Wainwright
Source: Buzz FX / 16 Nov 2024 14:40:19 America/Chicago
Y-mAbs Therapeutics' (YMAB) Buy Rating Reaffirmed at HC Wainwright Written by MarketBeat November 16, 2024 Share Link copied to clipboard. Y-mAbs Therapeutics ( NASDAQ:YMAB - Get Free Report ) 's stock had its "buy" rating reiterated by ana
Read more...